The size of the Protein Expression Market in the Asia Pacific was worth 505.98 million in 2021 and is estimated to be growing at a CAGR of 12.44%, to reach 909.36 million by 2026.
Protein expression is the process of altering, synthesizing, and controlling the proteins in living organisms. Proteins are controlled and manufactured depending upon the practical need in the host cell. Biotechnology-based companies create novel therapeutics with negligible side effects, thereby generating a huge market for Protein expression.
Y-O-Y rise in the prevalence of chronic diseases such as diabetes, cardiovascular diseases, heart-related diseases, and other illnesses in the APAC region is one of the key drivers promoting the growth of the protein expression market in APAC. In addition, an increase in the growing population is expected to be a plus to the development of the market during the forecast period. For instance, China and India hold the largest population in the world such that China has a total of 18.47% of the world share and India holds 17.70% of the world share; therefore, this implies the rapid increase in the growing need and demand for protein biologics which is increasing the demand of protein expression in the market in this region.
The growing number of technological advancements for developing new advanced techniques for getting rapid and effective results with accurate information is expected to uplift the market's growth rate. In addition, the increase in the government initiatives and support for research and development activities and movements in the pharma sector for manufacturing efficient medication with the rising awareness among the people about protein expression will help propel the market's growth.
Furthermore, an increase in the investments and fundings from government and non-government organizations in the biotechnology sector for manufacturing various methods and techniques for testing protein expression and an increase in the biologics market is further estimated to accelerate the growth of the Asia Pacific protein expression market.
However, an increase in the costs of the products with the lack of skilled and trained individuals for operating and analyzing the outputs from the device are affecting the growth of the APAC protein expression market. Also, the lack of standardization of protein expression to provide high-quality protein hinders the market growth. In addition, the strict government rules and regulations for introducing any product in the market with the stringent approval processes for approving products and services are affecting the market growth. Therefore, the other factor that is hampering the development of the Asia Pacific protein expression market is the increasing costs of the maintenance and installment of the equipment.
This research report on the Asia Pacific protein expression market has been segmented and sub-segmented into the following categories:
By Expression Systems:
By Products:
By Application:
By End User:
By Country:
Geographically, the Asia-Pacific protein expression market is one of the fastest-growing regions globally. Owing to the increase in the prevalence of the growing population with the rise in the geriatric population and improving the healthcare sector in the region, the APAC is expected to account for a significant share in the global market during the forecast period. In addition, the increasing investment by the government, raising awareness, medical tourism across the developing countries is boosting the market growth.
The Chinese protein expression market is forecasted to be playing a dominating role in the APAC region during the forecast period due to the prevalence of chronic diseases. Furthermore, as in China, non-communicable diseases (NCDs) account for 80 percent of fatalities, increasing the market growth. In addition, technological advancement in the healthcare sector, availability of well-established infrastructure, and favorable reimbursement policies contribute to the APAC protein expression market.
On the other hand, the Indian protein expression market is anticipated to contribute a promising share to the APAC market during the forecast period. In addition, market growth driven by increased investments and funding from government and non-government organizations in research activities is also encouraging market growth.
On the other hand, Japan and Australia are estimated to register healthy growth rates due to an increase in the initiatives for developing well-established medical and health care infrastructure in the region and increasing awareness among the people about protein expression, which is contributing to the market growth.
KEY MARKET PLAYERS:
Companies playing a leading role in the Asia-Pacific protein expression market profiled in the report are Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Expression System
5.1.1 Yeast Expression
5.1.2 Insect Expression
5.1.3 Cell-Free Expression
5.1.4 Bacterial Expression
5.1.5 Algal Expression
5.1.6 Mammalian Expression
5.2 By Product
5.2.1 Reagents
5.2.2 Services
5.2.3 Instruments
5.2.4 Others
5.3 By Application
5.3.1 Industrial Proteins
5.3.2 Cell Culture
5.3.3 Research
5.3.4 Therapeutic Proteins
5.3.5 Transfection technologies
5.3.6 Others
5.4 By End User
5.4.1 Biotechnology
5.4.2 Pharmaceutics
5.4.3 Academia
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Life Technologies Corporation
8.3 Bio-Rad Laboratories
8.4 New England BioLabs
8.5 Merck Millipore
8.6 Takara Bio
8.7 Thermo Fisher Scientific
8.8 Promega Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
11. Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
